Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat

M. E. De Jonge; A. D.R. Huitema; J. H. Beijnen; J. H.M. Schellens; S. Rodenhuis

Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat

M. E. De Jonge, A. D.R. Huitema, J. H. Beijnen, J. H.M. Schellens, S. Rodenhuis

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

1 Citaat (Scopus)

Samenvatting

Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.

Vertaalde titel van de bijdrage	Successful rechallenge with cromoglycate prophylaxis. Hypersensitivity reaction in chemotherapy
Originele taal-2	Nederlands
Pagina's (van-tot)	874-878
Aantal pagina's	5
Tijdschrift	Pharmaceutisch Weekblad
Volume	138
Nummer van het tijdschrift	25
Status	Gepubliceerd - 20 jun. 2003
Extern gepubliceerd	Ja

Trefwoorden

Antineoplastic agents
Case report
Cromoglycic acid
Hypersensitivity

Citeer dit

@article{56dfd47647824be6962a815bf7150db5,

title = "Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat",

abstract = "Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.",

keywords = "Antineoplastic agents, Case report, Cromoglycic acid, Hypersensitivity",

author = "{De Jonge}, {M. E.} and Huitema, {A. D.R.} and Beijnen, {J. H.} and Schellens, {J. H.M.} and S. Rodenhuis",

year = "2003",

month = jun,

day = "20",

language = "Nederlands",

volume = "138",

pages = "874--878",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "25",

}

TY - JOUR

T1 - Overevoeligheidsreactie bij chemotherapie

T2 - Succesvolle 'rechallenge' met cromoglicaat

AU - De Jonge, M. E.

AU - Huitema, A. D.R.

AU - Beijnen, J. H.

AU - Schellens, J. H.M.

AU - Rodenhuis, S.

PY - 2003/6/20

Y1 - 2003/6/20

N2 - Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.

AB - Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.

KW - Antineoplastic agents

KW - Case report

KW - Cromoglycic acid

KW - Hypersensitivity

UR - http://www.scopus.com/inward/record.url?scp=0038611020&partnerID=8YFLogxK

M3 - Artikel

AN - SCOPUS:0038611020

SN - 0031-6911

VL - 138

SP - 874

EP - 878

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 25

ER -

Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat

Samenvatting

Trefwoorden

Vingerafdruk

Citeer dit